Physical Activity and Fatigue in Early Multiple Sclerosis (MS)
Launched by BAYER · Apr 15, 2009
Trial Information
Current as of June 10, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Multiple sclerosis diagnosed within the last 12 months
- • Clinically isolated Syndrome (CIS), under Interferon-beta-1b treatment
About Bayer
Bayer is a global healthcare and life sciences company dedicated to advancing health and well-being through innovative research and development. With a strong commitment to improving patient outcomes, Bayer conducts clinical trials across various therapeutic areas, including oncology, cardiology, and women's health. The company leverages cutting-edge science and technology to develop breakthrough therapies, while adhering to the highest standards of ethical practices and regulatory compliance. Through collaboration with healthcare professionals and research institutions, Bayer aims to bring transformative solutions to the market, ultimately enhancing the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Many Locations, , Italy
Many Locations, , Australia
Many Locations, , Austria
Many Locations, , Colombia
Many Locations, , Czech Republic
Many Locations, , Germany
Many Locations, , Indonesia
Many Locations, , Jordan
Many Locations, , Kazakhstan
Many Locations, , Korea, Republic Of
Many Locations, , Lebanon
Many Locations, , Mexico
Many Locations, , Slovenia
Many Locations, , Spain
Many Locations, , Taiwan
Many Locations, , Thailand
Many Locations, , United Kingdom
Many Locations, , Belgium
Many Locations, , Canada
Many Locations, , Denmark
Many Locations, , France
Many Locations, , Israel
Many Locations, , Netherlands
Many Locations, , Norway
Many Locations, , Sweden
Many Locations, , Switzerland
Many Locations, , Bahrain
Many Locations, , Egypt
Many Locations, , Kuwait
Many Locations, , Portugal
Many Locations, , United Arab Emirates
Many Locations, , Greece
Many Locations, , Oman
Patients applied
Trial Officials
Bayer Study Director
Study Director
Bayer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials